Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
Shaina D'Lee Templeton(University of Saskatchewan), Shahid Ahmed(Emory University), Mike Moser(Roswell Park Comprehensive Cancer Center), Christopher J Wall(Royal University Hospital), Yigan Luo(University of Saskatchewan), John M. Shaw(University of Saskatchewan), Adnan Zaidi(University of Saskatchewan), Haji Chalchal
Cited by 6
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Diffuse axonal injury in children: Clinical correlation with hemorrhagic lesions
|Annals of Neurology|2004|344
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia
|New England Journal of Medicine|1977|299